
SNY
$50.71
| Revenue | $13170Mn | 
| Net Profits | $2802Mn | 
| Net Profit Margins | 21.28% | 
Sanofi’s revenue fell -6.97% since last year same period to $13170Mn in the Q3 2025. On a quarterly growth basis, Sanofi has generated 22.68% jump in its revenue since last 3-months.
Sanofi’s net profit fell -0.46% since last year same period to $2802Mn in the Q3 2025. On a quarterly growth basis, Sanofi has generated -28.88% fall in its net profits since last 3-months.
Sanofi’s net profit margin jumped 7% since last year same period to 21.28% in the Q3 2025. On a quarterly growth basis, Sanofi has generated -42.03% fall in its net profit margins since last 3-months.
| EPS Estimate Current Quarter | 1.62 | 
| EPS Estimate Current Year | 1.62 | 
Sanofi’s earning per share (EPS) estimates for the current quarter stand at 1.62 - a 62% jump from last quarter’s estimates.
Sanofi’s earning per share (EPS) estimates for the current year stand at 1.62.
| Earning Per Share (EPS) | 0.91 | 
| Dividend Per Share (DPS) | 2.21 | 
Sanofi’s earning per share (EPS) fell -2.15% since last year same period to 0.91 in the Q2 2025. This indicates that the Sanofi has generated -2.15% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Sanofi declared 2.21 dividend per share during the earnings announcement for Q2 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % | 
|---|---|---|---|
| 2025-03-31 | 0.95 | 1.02 | 7.37% | 
| 2025-07-31 | 1 | 0.91 | -9% |